BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alibaba
BABA
|
+$1.45B |
| 2 |
Visa
V
|
+$458M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$431M |
| 4 |
DuPont de Nemours
DD
|
+$308M |
| 5 |
NVIDIA
NVDA
|
+$299M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$705M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$430M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$256M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Healthcare | 10.5% |
| 4 | Financials | 8.72% |
| 5 | Industrials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Factset
FDS
$13.7B
| $5.84M | 0.01% |
14,574
-12,387
| -46% | -$4.96M |
|
777
Erie Indemnity
ERIE
$17.3B
| $5.78M | 0.01% |
27,503
-370
| -1% | -$77.7K |
|
778
Viavi Solutions
VIAV
$2.66B
| $5.76M | 0.01% |
508,422
+135,167
| +36% | +$1.53M |
|
|
RETA
779
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.75M | 0.01% |
56,365
+22,601
| +67% | +$2.3M |
|
780
Avery Dennison
AVY
$12.8B
| $5.74M | 0.01% |
33,431
-25,793
| -44% | -$4.43M |
|
781
BHP
BHP
$135B
| $5.74M | 0.01% |
96,244
-49,118
| -34% | -$2.93M |
|
782
Pathward Financial
CASH
$1.74B
| $5.74M | 0.01% |
123,783
-45,313
| -27% | -$2.1M |
|
783
LKQ Corp
LKQ
$8.26B
| $5.72M | 0.01% |
98,128
-22,134
| -18% | -$1.29M |
|
784
Alaska Air
ALK
$7.22B
| $5.67M | 0.01% |
106,577
-3,865
| -3% | -$206K |
|
785
Ormat Technologies
ORA
$5.51B
| $5.64M | 0.01% |
70,084
-4,916
| -7% | -$396K |
|
786
Global Partners
GLP
$1.77B
| $5.63M | 0.01% |
183,161
+131,607
| +255% | +$4.04M |
|
787
Perion Network
PERI
$415M
| $5.62M | 0.01% |
183,354
+28,233
| +18% | +$866K |
|
788
RH
RH
$4.29B
| $5.62M | 0.01% |
17,041
-17,512
| -51% | -$5.77M |
|
789
Establishment Labs
ESTA
$1.1B
| $5.62M | 0.01% |
81,859
+81,579
| +29,135% | +$5.6M |
|
|
RVNC
790
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.61M | 0.01% |
221,809
-83,372
| -27% | -$2.11M |
|
791
Protagonist Therapeutics
PTGX
$3.59B
| $5.59M | 0.01% |
202,310
-35,314
| -15% | -$975K |
|
792
Kilroy Realty
KRC
$4.98B
| $5.58M | 0.01% |
185,507
+97,936
| +112% | +$2.95M |
|
793
Huntsman Corp
HUN
$1.88B
| $5.57M | 0.01% |
206,029
-137,466
| -40% | -$3.71M |
|
794
Sanofi
SNY
$115B
| $5.54M | 0.01% |
102,737
+99,274
| +2,867% | +$5.35M |
|
795
NiSource
NI
$19.2B
| $5.52M | 0.01% |
201,683
-94,400
| -32% | -$2.58M |
|
796
Integer Holdings
ITGR
$3.59B
| $5.5M | 0.01% |
62,099
+9,614
| +18% | +$852K |
|
797
NovoCure
NVCR
$1.37B
| $5.5M | 0.01% |
132,585
+100,235
| +310% | +$4.16M |
|
798
Under Armour
UAA
$2.14B
| $5.5M | 0.01% |
761,220
-565,384
| -43% | -$4.08M |
|
799
GDS Holdings
GDS
$6.42B
| $5.48M | 0.01% |
498,756
+421,706
| +547% | +$4.63M |
|
800
Bruker
BRKR
$4.63B
| $5.48M | 0.01% |
74,095
+14,635
| +25% | +$1.08M |
|